Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA-Reference-Cited by-同舟云学术

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA

Published:2013-07-06 Issue:10 Volume:66 Page:854-861
ISSN:0021-9746
Container-title:Journal of Clinical Pathology
language:en
Short-container-title:J Clin Pathol

Author:

Henderson Douglas W,Reid Glen,Kao Steven C,van Zandwijk Nico,Klebe Sonja

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference128 articles.

1. The pathology of mesothelioma, including immunohistology and ultrastructure;Henderson,1992

2. Neoplastic asbestos-induced disease;Churg,1998

3. Mesothelioma;Churg,2004

4. Neoplasms of the pleura;Hammar,2008

5. International mesothelioma panel;Brambilla,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium;Surgical Pathology Clinics;2024-06

2. Mesothelioma: Pleural, Version 1.2024;Journal of the National Comprehensive Cancer Network;2024-03

3. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-09

4. Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates;Current Oncology Reports;2023-02-10

5. Incidence and mortality from malignant mesothelioma 1982–2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry;Occupational and Environmental Medicine;2023-02-08